AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Ciprofloxacin Hydrochloride USP in Rwanda
3 products registered with RDA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CIPROKANT-500 Tablets | Rwanda FDA-HMP-MA-1731 | S KANT HEALTHCARE LTD | active | 16 Aug 2029 |
| CIPROLAB-500 TABLETS Tablets | Rwanda FDA-HMP-MA-1732 | LABORATORY & ALLIED LTD | active | 16 Aug 2029 |
| CIPROFLOXACIN HYDROCHLORIDE USP TABLETS | Rwanda FDA-HMP-MA-2130 | GRACURE PHARMACEUTICALS LIMITED | active | 17 Feb 2029 |
Ciprofloxacin Hydrochloride USP — RDA Registration Details
RDA (Rwanda) has 3 registered products containing Ciprofloxacin Hydrochloride USP, of which 3 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Ciprofloxacin Hydrochloride USP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.